Pharmacokinetics and Pharmacodynamics of Clofazimine for Treatment of Cryptosporidiosis

Infection with Cryptosporidium spp. can cause severe diarrhea, leading to long-term adverse impacts and even death in malnourished children and immunocompromised patients. The only FDA-approved drug for treating cryptosporidiosis, nitazoxanide, has limited efficacy in the populations impacted the mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Cindy X., Love, Melissa S., McNamara, Case W., Chi, Victor, Woods, Ashley K., Joseph, Sean, Schaefer, Deborah A., Betzer, Dana P., Riggs, Michael W., Iroh Tam, Pui-Ying, Van Voorhis, Wesley C., Arnold, Samuel L. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765308/
https://www.ncbi.nlm.nih.gov/pubmed/34748385
http://dx.doi.org/10.1128/AAC.01560-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765308/
https://www.ncbi.nlm.nih.gov/pubmed/34748385
http://dx.doi.org/10.1128/AAC.01560-21

Ejemplares similares